Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding.
D001952:Bridged-Ring Compounds / Q000494:pharmacology; D050882:CREB-Binding Protein; D002460:Cell Line; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004847:Epithelial Cells; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D008168:Lung / Q000166:cytology; D016328:NF-kappa B / Q000378:metabolism; D009636:Norbornanes; D009687:Nuclear Proteins / Q000378:metabolism; D020033:Protein Isoforms / Q000037:antagonists & inhibitors; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D013859:Thiocarbamates; D013871:Thiones / Q000494:pharmacology; D015534:Trans-Activators / Q000378:metabolism; D051996:Transcription Factor RelA; D015533:Transcriptional Activation / Q000187:drug effects*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
D001952:Bridged-Ring Compounds; D004791:Enzyme Inhibitors; D007211:Indoles; D016328:NF-kappa B; D009636:Norbornanes; D009687:Nuclear Proteins; D020033:Protein Isoforms; D013859:Thiocarbamates; D013871:Thiones; D015534:Trans-Activators; D051996:Transcription Factor RelA; D014409:Tumor Necrosis Factor-alpha; C046498:tricyclodecane-9-yl-xanthogenate; D050882:CREB-Binding Protein; C494363:CREBBP protein, human; D011493:Protein Kinase C; C064758:Ro 31-8220